CINA-ICH

Avicenna.AI

The CINA-ICH solution provides automated detection and prioritization of acute intracerebral hemorrhage on non-contrast CT (NCCT).
Product specifications Information source: Vendor
Last updated: June 29, 2021
General
Product name CINA-ICH
Company Avicenna.AI
Subspeciality Neuro
Modality CT
Disease targeted Intracranial Hemorrhage, Stroke, Trauma
Key-features Intracranial Hemorrhage detection, notification
Suggested use Before: adapting worklist order, flagging acute findings
Data characteristics
Population Suspicion of stroke, Suspicion of head trauma
Input non contrast CT
Input format DICOM
Output segmentation contour, worklist order, notification
Output format DICOM SC, GSPS
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds
Certification
CE
Certified, Class I , MDD
FDA
510(k) cleared, Class II
Market presence
On market since 02-2020
Distribution channels Eureka Clinical AI, Canon Automation Platform, Blackford, Arterys, Nuance AI Marketplace
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance

  • Assessment of an Artificial Intelligence Algorithm for Detection of Intracranial Hemorrhage (read)

  • Validation of a Deep Learning Tool in the Detection of Intracranial Hemorrhage and Large Vessel Occlusion (read)

Non-peer reviewed papers on performance
Other relevant papers